ACADIA Pharmaceuticals
ACAD
#3223
Rank
C$6.27 B
Marketcap
C$37.07
Share price
-2.48%
Change (1 day)
39.66%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2025 (TTM): C$0.38 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are C$1.04 Billion. In 2024 the company made an earning of C$0.35 Billion, an increase over its 2023 earnings that were of -C$70.7 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$0.38 B8.52%
2024 C$0.35 B-605.67%
2023 -C$70.7 Million-76.09%
2022 -C$0.3 Billion27.41%
2021 -C$0.24 Billion-40.38%
2020 -C$0.39 Billion19.88%
2019 -C$0.33 Billion-3.92%
2018 -C$0.34 Billion-15.04%
2017 -C$0.4 Billion6.33%
2016 -C$0.38 Billion64.55%
2015 -C$0.23 Billion77.47%
2014 -C$0.13 Billion143.69%
2013 -C$52.57 Million81.93%
2012 -C$28.9 Million-8.73%
2011 -C$31.66 Million-251.39%
2010 C$20.9 M-133.2%
2009 -C$62.99 Million-30.82%
2008 -C$91.04 Million6.43%
2007 -C$85.55 Million25.89%
2006 -C$67.95 Million36.99%
2005 -C$49.6 Million37.22%
2004 -C$36.15 Million19.96%
2003 -C$30.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Vanda Pharmaceuticals
VNDA
-C$0.17 Billion-144.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.41 B 4,230.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.17 B 8,122.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.87 B 11,737.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$11.12 B 2,835.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-C$53.51 Million-114.12%๐Ÿ‡บ๐Ÿ‡ธ USA